Skip to main content
All lobbying filings

COHERUS BIOSCIENCES

COHERUS BIOSCIENCES filed a Q2 report for COHERUS BIOSCIENCES, INC. on August 18, 2025.

Lobbying for COHERUS BIOSCIENCES, INC.

All filings by COHERUS BIOSCIENCES · Everything COHERUS BIOSCIENCES, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Aug 18, 2025
Expenses
$125,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • DAVID SANDERS
    Previously held: Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 2

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem